Purchases and Sales Made in Q3 2022 in Ideaya Biosciences, Inc. (IDYA)
This table provides information about the institutional ownership of Ideaya Biosciences, Inc. (IDYA) during Q3 2022. The information is specifically focused on institutions that hold shares of IDEAYA Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-27.4K- 1.45% |
$253K - $432K
|
1.86M
$51.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-37K- 43.02% |
$342K - $585K
|
49K
$1.36M
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-98K- 48.15% |
$905K - $1.55M
|
106K
$2.93M
|
|
|
Nov 14, 2022
Q3 2022
|
5 Am Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-202K- 14.43% |
$1.86M - $3.19M
|
1.2M
$33.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Alphabet Inc.
Mountain View, CA |
SELL
|
- |
-753KClosed |
$6.96M - $11.9M
|
0
$0
|